A carregar...
Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.
The effectiveness of intranasal neostigmine (9.3-13.8 mg) was tested in 20 subjects with myasthenia gravis, classified as Osserman grades 2A and 2B. In all cases the drug produced significant clinical and electromyographic improvement. No side effects were reported during the treatment.
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1991
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1014678/ https://ncbi.nlm.nih.gov/pubmed/1783916 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|